GSK plc (GLAXF)
USD 20.85
(0.63%)
USD 20.85
(0.63%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 30.32 Billion GBP | 3.42% |
| 2022 | 29.32 Billion GBP | -14.04% |
| 2021 | 34.11 Billion GBP | 0.04% |
| 2020 | 34.09 Billion GBP | 1.02% |
| 2019 | 33.75 Billion GBP | 9.52% |
| 2018 | 30.82 Billion GBP | 2.1% |
| 2017 | 30.18 Billion GBP | 8.24% |
| 2016 | 27.88 Billion GBP | 16.58% |
| 2015 | 23.92 Billion GBP | 3.99% |
| 2014 | 23 Billion GBP | -13.2% |
| 2013 | 26.5 Billion GBP | 0.28% |
| 2012 | 26.43 Billion GBP | -3.49% |
| 2011 | 27.38 Billion GBP | -3.54% |
| 2010 | 28.39 Billion GBP | 0.08% |
| 2009 | 28.36 Billion GBP | 16.49% |
| 2008 | 24.35 Billion GBP | 7.2% |
| 2007 | 22.71 Billion GBP | -2.19% |
| 2006 | 23.22 Billion GBP | 7.23% |
| 2005 | 21.66 Billion GBP | 8.38% |
| 2004 | 19.98 Billion GBP | -6.79% |
| 2003 | 21.44 Billion GBP | 1.08% |
| 2002 | 21.21 Billion GBP | 3.3% |
| 2001 | 20.53 Billion GBP | 13.58% |
| 2000 | 18.07 Billion GBP | 112.94% |
| 1999 | 8.49 Billion GBP | 6.35% |
| 1998 | 7.98 Billion GBP | 0.04% |
| 1997 | 7.98 Billion GBP | -4.33% |
| 1996 | 8.34 Billion GBP | -20.49% |
| 1995 | 10.49 Billion GBP | 85.47% |
| 1994 | 5.65 Billion GBP | 14.73% |
| 1993 | 4.93 Billion GBP | 20.36% |
| 1992 | 4.09 Billion GBP | 20.58% |
| 1991 | 3.39 Billion GBP | 6.86% |
| 1990 | 3.17 Billion GBP | 23.7% |
| 1989 | 2.57 Billion GBP | 24.82% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 7.88 Billion GBP | 7.08% |
| 2024 Q1 | 7.36 Billion GBP | -8.56% |
| 2024 Q3 | 8.01 Billion GBP | 1.62% |
| 2023 FY | 30.32 Billion GBP | 3.42% |
| 2023 Q4 | 8.05 Billion GBP | -1.17% |
| 2023 Q1 | 6.95 Billion GBP | -5.76% |
| 2023 Q2 | 7.17 Billion GBP | 3.27% |
| 2023 Q3 | 8.14 Billion GBP | 13.5% |
| 2022 Q3 | 7.82 Billion GBP | 12.99% |
| 2022 Q1 | 9.78 Billion GBP | 2.66% |
| 2022 Q2 | 6.92 Billion GBP | -29.15% |
| 2022 FY | 29.32 Billion GBP | -14.04% |
| 2022 Q4 | 7.37 Billion GBP | -5.79% |
| 2021 Q1 | 7.41 Billion GBP | -15.12% |
| 2021 Q4 | 9.52 Billion GBP | 4.96% |
| 2021 Q3 | 9.07 Billion GBP | 12.17% |
| 2021 Q2 | 8.09 Billion GBP | 9.09% |
| 2021 FY | 34.11 Billion GBP | 0.04% |
| 2020 FY | 34.09 Billion GBP | 1.02% |
| 2020 Q4 | 8.73 Billion GBP | 1.08% |
| 2020 Q1 | 9.09 Billion GBP | 2.15% |
| 2020 Q3 | 8.64 Billion GBP | 13.41% |
| 2020 Q2 | 7.62 Billion GBP | -16.13% |
| 2019 Q3 | 9.38 Billion GBP | 20.18% |
| 2019 Q1 | 7.66 Billion GBP | -6.54% |
| 2019 Q4 | 8.89 Billion GBP | -5.18% |
| 2019 Q2 | 7.8 Billion GBP | 1.93% |
| 2019 FY | 33.75 Billion GBP | 9.52% |
| 2018 Q4 | 8.19 Billion GBP | 1.3% |
| 2018 Q2 | 7.31 Billion GBP | 1.22% |
| 2018 Q1 | 7.22 Billion GBP | -5.46% |
| 2018 FY | 30.82 Billion GBP | 2.1% |
| 2018 Q3 | 8.09 Billion GBP | 10.7% |
| 2017 Q1 | 7.38 Billion GBP | -2.66% |
| 2017 Q3 | 7.84 Billion GBP | 7.14% |
| 2017 Q2 | 7.32 Billion GBP | -0.87% |
| 2017 FY | 30.18 Billion GBP | 8.24% |
| 2017 Q4 | 7.63 Billion GBP | -2.6% |
| 2016 Q1 | 6.22 Billion GBP | -0.91% |
| 2016 Q2 | 6.53 Billion GBP | 4.86% |
| 2016 FY | 27.88 Billion GBP | 16.58% |
| 2016 Q3 | 7.54 Billion GBP | 15.46% |
| 2016 Q4 | 7.58 Billion GBP | 0.58% |
| 2015 Q3 | 6.12 Billion GBP | 4.06% |
| 2015 Q2 | 5.88 Billion GBP | 4.73% |
| 2015 Q1 | 5.62 Billion GBP | -9.12% |
| 2015 Q4 | 6.28 Billion GBP | 2.6% |
| 2015 FY | 23.92 Billion GBP | 3.99% |
| 2014 Q3 | 5.64 Billion GBP | 1.53% |
| 2014 Q4 | 6.18 Billion GBP | 9.56% |
| 2014 Q2 | 5.56 Billion GBP | -0.93% |
| 2014 Q1 | 5.61 Billion GBP | -18.72% |
| 2014 FY | 23 Billion GBP | -13.2% |
| 2013 Q4 | 6.9 Billion GBP | 6.08% |
| 2013 Q3 | 6.51 Billion GBP | -1.63% |
| 2013 Q2 | 6.61 Billion GBP | 2.27% |
| 2013 Q1 | 6.47 Billion GBP | -4.87% |
| 2013 FY | 26.5 Billion GBP | 0.28% |
| 2012 FY | 26.43 Billion GBP | -3.49% |
| 2012 Q4 | 6.8 Billion GBP | 4.21% |
| 2012 Q3 | 6.52 Billion GBP | 1.01% |
| 2012 Q2 | 6.46 Billion GBP | -2.68% |
| 2012 Q1 | 6.64 Billion GBP | -4.84% |
| 2011 FY | 27.38 Billion GBP | -3.54% |
| 2011 Q2 | 6.72 Billion GBP | 2.05% |
| 2011 Q3 | 7.1 Billion GBP | 5.71% |
| 2011 Q1 | 6.58 Billion GBP | -8.5% |
| 2011 Q4 | 6.97 Billion GBP | -1.77% |
| 2010 FY | 28.39 Billion GBP | 0.08% |
| 2010 Q3 | 6.81 Billion GBP | -3.02% |
| 2010 Q4 | 7.19 Billion GBP | 5.64% |
| 2010 Q1 | 7.35 Billion GBP | -9.11% |
| 2010 Q2 | 7.02 Billion GBP | -4.51% |
| 2009 Q3 | 6.75 Billion GBP | 0.16% |
| 2009 FY | 28.36 Billion GBP | 16.49% |
| 2009 Q4 | 8.09 Billion GBP | 19.77% |
| 2009 Q1 | 6.76 Billion GBP | -2.04% |
| 2009 Q2 | 6.74 Billion GBP | -0.33% |
| 2008 FY | 24.35 Billion GBP | 7.2% |
| 2008 Q1 | 5.68 Billion GBP | -5.18% |
| 2008 Q4 | 6.91 Billion GBP | 17.48% |
| 2008 Q3 | 5.88 Billion GBP | 0.14% |
| 2008 Q2 | 5.87 Billion GBP | 3.31% |
| 2007 Q2 | 5.67 Billion GBP | 1.47% |
| 2007 Q1 | 5.59 Billion GBP | -6.04% |
| 2007 Q3 | 5.47 Billion GBP | -3.5% |
| 2007 FY | 22.71 Billion GBP | -2.19% |
| 2007 Q4 | 5.99 Billion GBP | 9.52% |
| 2006 Q2 | 5.81 Billion GBP | 0.01% |
| 2006 Q4 | 5.95 Billion GBP | 5.49% |
| 2006 Q1 | 5.81 Billion GBP | -1.51% |
| 2006 Q3 | 5.64 Billion GBP | -2.95% |
| 2006 FY | 23.22 Billion GBP | 7.23% |
| 2005 Q2 | 5.23 Billion GBP | 4.02% |
| 2005 Q3 | 5.47 Billion GBP | 4.44% |
| 2005 Q4 | 5.9 Billion GBP | 7.88% |
| 2005 FY | 21.66 Billion GBP | 8.38% |
| 2005 Q1 | 5.03 Billion GBP | -10.07% |
| 2004 FY | 19.98 Billion GBP | -6.79% |
| 2004 Q4 | 5.59 Billion GBP | 13.69% |
| 2004 Q2 | 4.97 Billion GBP | 2.39% |
| 2004 Q3 | 4.92 Billion GBP | -0.92% |
| 2004 Q1 | 4.85 Billion GBP | -9.26% |
| 2003 Q1 | 5.27 Billion GBP | -6.9% |
| 2003 FY | 21.44 Billion GBP | 1.08% |
| 2003 Q4 | 5.35 Billion GBP | -2.12% |
| 2003 Q3 | 5.46 Billion GBP | 2.74% |
| 2003 Q2 | 5.32 Billion GBP | 0.82% |
| 2002 Q4 | 5.66 Billion GBP | 12.93% |
| 2002 Q1 | 5.11 Billion GBP | -9.73% |
| 2002 FY | 21.21 Billion GBP | 3.3% |
| 2002 Q2 | 5.41 Billion GBP | 5.97% |
| 2002 Q3 | 5.01 Billion GBP | -7.31% |
| 2001 Q4 | 5.66 Billion GBP | 13.36% |
| 2001 FY | 20.53 Billion GBP | 13.58% |
| 2001 Q1 | 4.75 Billion GBP | -5.41% |
| 2001 Q2 | 5.12 Billion GBP | 7.67% |
| 2001 Q3 | 4.99 Billion GBP | -2.5% |
| 2000 FY | 18.07 Billion GBP | 112.94% |
| 2000 Q1 | 4.09 Billion GBP | 79.52% |
| 2000 Q2 | 4.53 Billion GBP | 10.73% |
| 2000 Q3 | 4.42 Billion GBP | -2.23% |
| 2000 Q4 | 5.02 Billion GBP | 13.55% |
| 1999 Q3 | 2.27 Billion GBP | 10.77% |
| 1999 Q2 | 2.05 Billion GBP | 2.12% |
| 1999 FY | 8.49 Billion GBP | 6.35% |
| 1999 Q1 | 2.01 Billion GBP | -2.51% |
| 1999 Q4 | 2.27 Billion GBP | 0.13% |
| 1998 Q2 | 1.93 Billion GBP | 0.0% |
| 1998 Q1 | 1.93 Billion GBP | 5.0% |
| 1998 Q4 | 2.06 Billion GBP | 0.32% |
| 1998 FY | 7.98 Billion GBP | 0.04% |
| 1998 Q3 | 2.05 Billion GBP | 6.5% |
| 1997 Q4 | 1.83 Billion GBP | -8.13% |
| 1997 Q3 | 2 Billion GBP | -0.5% |
| 1997 Q2 | 2.01 Billion GBP | -1.58% |
| 1997 Q1 | 2.04 Billion GBP | -39.2% |
| 1997 FY | 7.98 Billion GBP | -4.33% |
| 1996 Q4 | 3.36 Billion GBP | 35.14% |
| 1996 Q3 | 2.48 Billion GBP | 19.0% |
| 1996 Q1 | 2.12 Billion GBP | 0.0% |
| 1996 FY | 8.34 Billion GBP | -20.49% |
| 1996 Q2 | 2.09 Billion GBP | -1.69% |
| 1995 FY | 10.49 Billion GBP | 85.47% |
| 1995 Q3 | 1.62 Billion GBP | -3.35% |
| 1995 Q2 | 1.68 Billion GBP | 5.53% |
| 1995 Q1 | 1.59 Billion GBP | -3.17% |
| 1994 FY | 5.65 Billion GBP | 14.73% |
| 1994 Q1 | 1.51 Billion GBP | 6.89% |
| 1994 Q2 | 1.31 Billion GBP | -13.57% |
| 1994 Q3 | 1.63 Billion GBP | 24.39% |
| 1994 Q4 | 1.65 Billion GBP | 1.03% |
| 1993 Q3 | 1.39 Billion GBP | 27.31% |
| 1993 Q2 | 1.09 Billion GBP | -27.5% |
| 1993 Q1 | 1.5 Billion GBP | 31.64% |
| 1993 FY | 4.93 Billion GBP | 20.36% |
| 1993 Q4 | 1.42 Billion GBP | 2.05% |
| 1992 Q3 | 977.28 Million GBP | 32.74% |
| 1992 Q4 | 1.14 Billion GBP | 17.3% |
| 1992 FY | 4.09 Billion GBP | 20.58% |
| 1992 Q1 | 1.11 Billion GBP | 7.51% |
| 1992 Q2 | 736.26 Million GBP | -34.26% |
| 1991 FY | 3.39 Billion GBP | 6.86% |
| 1991 Q1 | 793.32 Million GBP | 10.95% |
| 1991 Q4 | 1.04 Billion GBP | -6.3% |
| 1991 Q3 | 1.11 Billion GBP | 9.3% |
| 1991 Q2 | 1.01 Billion GBP | 28.2% |
| 1990 Q4 | 715 Million GBP | -2.76% |
| 1990 Q1 | 784.13 Million GBP | 4.18% |
| 1990 FY | 3.17 Billion GBP | 23.7% |
| 1990 Q2 | 924.24 Million GBP | 17.87% |
| 1990 Q3 | 735.3 Million GBP | -20.44% |
| 1989 Q3 | 743.77 Million GBP | -5.75% |
| 1989 Q2 | 789.11 Million GBP | 35.63% |
| 1989 Q1 | 581.8 Million GBP | 3.51% |
| 1989 FY | 2.57 Billion GBP | 24.82% |
| 1989 Q4 | 752.7 Million GBP | 1.2% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AstraZeneca PLC | 46.91 Billion USD | 35.355% |
| Bristol-Myers Squibb Company PFD CONV 2 | 45 Billion USD | 32.613% |
| CSPC Pharmaceutical Group Limited | 31.45 Billion USD | 3.568% |
| Clarus Therapeutics Holdings, Inc. | 13.95 Million USD | -217195.981% |
| Novartis AG | 46.66 Billion USD | 35.002% |
| PT Kalbe Farma Tbk. | 1.97 Billion USD | -1432.341% |